Form 8-K - Current report:
SEC Accession No. 0001206774-16-004051
Filing Date
2016-01-11
Accepted
2016-01-11 08:00:49
Documents
17
Period of Report
2016-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron_8k.htm 8-K 13673
2 JANUARY 2016 CORPORATE PRESENTATION HANDOUT exhibit99-1.htm EX-99.1 2513
3 GRAPHIC exhibit99-10001.jpg GRAPHIC 165157
4 GRAPHIC exhibit99-10002.jpg GRAPHIC 370944
5 GRAPHIC exhibit99-10003.jpg GRAPHIC 252017
6 GRAPHIC exhibit99-10004.jpg GRAPHIC 258274
7 GRAPHIC exhibit99-10005.jpg GRAPHIC 207361
8 GRAPHIC exhibit99-10006.jpg GRAPHIC 241715
9 GRAPHIC exhibit99-10007.jpg GRAPHIC 276526
10 GRAPHIC exhibit99-10008.jpg GRAPHIC 230986
11 GRAPHIC exhibit99-10009.jpg GRAPHIC 232129
12 GRAPHIC exhibit99-10010.jpg GRAPHIC 200002
13 GRAPHIC exhibit99-10011.jpg GRAPHIC 231700
14 GRAPHIC exhibit99-10012.jpg GRAPHIC 260498
15 GRAPHIC exhibit99-10013.jpg GRAPHIC 192753
16 GRAPHIC exhibit99-10014.jpg GRAPHIC 132567
17 GRAPHIC exhibit99-10015.jpg GRAPHIC 28918
  Complete submission text file 0001206774-16-004051.txt   4534775
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 161335076
SIC: 2834 Pharmaceutical Preparations